Literature DB >> 15608321

Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.

C van Noord, H Hooijkaas, B C M Dufour-van den Goorbergh, P M van Hagen, P L A van Daele, J P van de Merwe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15608321      PMCID： PMC1755177          DOI： 10.1136/ard.2004.021477

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis.

Authors:  James J Son; Mariko Ishimori; James Mirocha; Michael H Weisman; Lindsy J Forbess
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

2.  Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.

Authors:  Yufeng Yin; Di Liang; Lidan Zhao; Yang Li; Wei Liu; Yan Ren; Yongzhe Li; Xiaofeng Zeng; Fengchun Zhang; Fulin Tang; Guangliang Shan; Xuan Zhang
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.